The decrease in expression of PPARα in carcinoma samples in comparison to normal tissue was detected in 15/37 patients (i.e., 40.5%), the increase in 14/37 (37.8%) patients and 8/37 (21.6%) patients samples showed the same staining intensity for normal and tumour tissue samples. Here, PPARA is linked to carcinoma.